Lyra Therapeutics (LYRA) Net Income (2019 - 2025)

Quarterly Net Income rose 36.69% to -$7.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$28.9 million through Dec 2025, up 69.05% year-over-year, with the annual reading at -$28.9 million for FY2025, 69.05% up from the prior year.

Lyra Therapeutics' Net Income history spans 7 years, with the latest figure at -$7.0 million for Q4 2025.

  • Net Income came in at -$7.0 million for Q4 2025, down from -$6.0 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of -$6.0 million in Q3 2025 to a low of -$48.1 million in Q2 2024.
  • The 5-year median for Net Income is -$12.8 million (2021), against an average of -$14.2 million.
  • Year-over-year, Net Income crashed 208.18% in 2024 and then skyrocketed 84.55% in 2025.
  • Lyra Therapeutics' Net Income stood at -$13.6 million in 2021, then fell by 4.44% to -$14.2 million in 2022, then decreased by 6.57% to -$15.2 million in 2023, then rose by 27.56% to -$11.0 million in 2024, then surged by 36.69% to -$7.0 million in 2025.
  • Per Business Quant, the three most recent readings for LYRA's Net Income are -$7.0 million (Q4 2025), -$6.0 million (Q3 2025), and -$7.4 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -2.99 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -8.50 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -14.46 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 1.03 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 727.20 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -3.40 Mn
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 205.99 Mn
10 Lyra Therapeutics - - - -6.95 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -6.95 Mn
Sep 30, 2025 -5.98 Mn
Jun 30, 2025 -7.44 Mn
Mar 31, 2025 -8.55 Mn
Dec 31, 2024 -10.98 Mn
Sep 30, 2024 -11.87 Mn
Jun 30, 2024 -48.13 Mn
Mar 31, 2024 -22.45 Mn
Dec 31, 2023 -15.16 Mn
Sep 30, 2023 -15.65 Mn
Jun 30, 2023 -15.62 Mn
Mar 31, 2023 -16.26 Mn
Dec 31, 2022 -14.22 Mn
Sep 30, 2022 -14.77 Mn
Jun 30, 2022 -14.37 Mn
Mar 31, 2022 -11.91 Mn
Dec 31, 2021 -13.62 Mn
Sep 30, 2021 -11.06 Mn
Jun 30, 2021 -11.04 Mn
Mar 31, 2021 -7.80 Mn
Dec 31, 2020 -7.02 Mn
Sep 30, 2020 -6.33 Mn
Jun 30, 2020 -4.54 Mn
Mar 31, 2020 -4.23 Mn
Dec 31, 2019 -4.35 Mn
Sep 30, 2019 -4.16 Mn
Jun 30, 2019 -4.20 Mn
Mar 31, 2019 -3.59 Mn